Gubra ASFRA:PI3 +1.71%73 Buyback Yield % is 0.08 as of Jul. 01, 2026, which is 700% above its 10-year median of 0.01. GuruFocus rates FRA:PI3 with a GF Score™ of 73/100 and a GF Value™ of €389.49 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 745 Biotechnology companies, Gubra AS ranks better than 88.86% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Gubra AS's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PI3 vs VRTX, REGN, ALNY: Buyback Yield % Comparison
For the Biotechnology subindustry, Gubra AS's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gubra AS Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gubra AS's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Gubra AS's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gubra AS (FRA:PI3) has a Buyback Yield % of 0.08 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Gubra AS and its competitors. This is 700% above median its historical median of 0.01. According to the industry distribution chart, Gubra AS ranks #83 out of 745 companies in the Biotechnology industry, placing it in the top 11.1%.
Is Gubra AS's Buyback Yield % too high?
Gubra AS's current Buyback Yield % of 0.08 is 700% above median its 10-year median of 0.01. Based on the distribution chart, Gubra AS ranks #83 out of 745 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Gubra AS has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gubra AS ranks #83 out of 745 companies for Buyback Yield %. This places Gubra AS in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Gubra AS and its competitors. Gubra AS's current Buyback Yield % is 0.08, which is 700% above median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (FRA:PI3) is currently considered Possible Value Trap. The stock's GF Value™ is €389.49, compared to a current price of €44.08 — trading 88.7% below its estimated fair value. The current Buyback Yield % is 0.08, which is 700% above median its 10-year median of 0.01. Gubra AS's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Gubra AS (FRA:PI3), the current Buyback Yield % is 0.08 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gubra AS (FRA:PI3) Overvalued in 2026?
Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued.
The current stock price of €44.08 is trading 88.7% below its estimated GF Value™ of €389.49.
GuruFocus considers Gubra AS to be Possible Value Trap.
Key valuation signals for FRA:PI3:
Buyback Yield %: 0.08 (700% above median its 10-year median of 0.01)
GF Value™: €389.49 vs. price of €44.08 (88.7% below fair value)
No single metric tells the full story. See the FRA:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
73GF Score
Get the complete analysis for FRA:PI3
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PI3 has been successfully added to your 
